Aug 2024 $3 M No. 5 $2 to $10 million 8
JumpCode Genomics, Inc.: Raise no. 5, Aug 2024 × Investors in this round 8 investors had bought by the notice of Aug 22, 2024: 8 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $3 M of $11 M offered; $8 M still to sell
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice David Michael Salter · Executive Officer, Director Court Michael Turner · Director Joseph Michael Lee · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “Totals include amounts receivable upon the exercise of warrants. Such warrants have not yet been exercised.”Signed by David Michael Salter, Chief Executive Officer. Source: SEC Form D, newest notice filed Aug 22, 2024. Read the notice at the SEC .
equity, options SEC Apr 2023 $9 M No. 4 $2 to $10 million 7
JumpCode Genomics, Inc.: Raise no. 4, Apr 2023 × Investors in this round 7 investors had bought by the notice of May 9, 2023: 7 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $9 M of $16 M offered; $7 M still to sell
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Brandon Poe · Executive Officer Yaron Hakak · Executive Officer, Director Court Turner · Director Dan Kidle · Director Frank Witney · Director Kirk Malloy · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “Totals include amounts receivable upon the exercise of issued and issuable warrants.”Signed by Yaron Hakak, Chief Executive Officer. Source: SEC Form D, newest notice filed May 9, 2023. Read the notice at the SEC .
equity, options SEC Dec 2020 $21 M No. 3 $10 to $50 million 5
JumpCode Genomics, Inc.: Raise no. 3, Dec 2020 × Investors in this round 5 investors had bought by the notice of Dec 26, 2020: 5 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $21 M of $21 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Keith Brown · Executive Officer Yaron Hakak · Executive Officer, Director Dan Kidle · Director Frank Witney · Director Kevin Li · Director Kirk Malloy · Director Michael Liang · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Yaron Hakak, Chief Executive Officer. Source: SEC Form D, newest notice filed Dec 26, 2020. Read the notice at the SEC .
equity SEC Jan 2020 $2 M No. 2 Under $2 million 1
JumpCode Genomics, Inc.: Raise no. 2, Jan 2020 × Investors in this round 1 investor had bought by the notice of Feb 11, 2020: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $2 M of $2 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Keith Brown · Executive Officer, Director Eugene Chen · Director Joel Rotroff · Director Kevin Li · Director Kirk Malloy · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Keith Brown, Chief Executive Officer. Source: SEC Form D, newest notice filed Feb 11, 2020. Read the notice at the SEC .
equity SEC Sep 2018 $4 M No. 1 $2 to $10 million 4
JumpCode Genomics, Inc.: Raise no. 1, Sep 2018 × Investors in this round 4 investors had bought by the notice of Sep 12, 2018: 4 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $4 M of $4 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Keith Brown · Executive Officer, Director Eugene Chen · Director Joel Rotroff · Director Kirk Malloy · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “$1,011,275.14 cancellation of indebtedness; $2,499,999.81 of new cash”Signed by Keith Brown, Chief Executive Officer. Source: SEC Form D, newest notice filed Sep 12, 2018. Read the notice at the SEC .
equity SEC